KLK3 and prostate carcinoma: Alternative technical approaches incorporate tissue-specific promoters to control key viral gene expression, as exemplified by prostate cancer-specific adenoviruses controlled by prostate-specific antigen (PSA) promoters that exhibit prostate-selective activity.